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CARING FOR THE
CRITICALLY ILL PATIENT
ONLINE FIRST
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C

RITICALLY ILL MECHANICALLY

ventilated patients receive intravenous sedative and analgesic medications to reduce
anxiety and promote comfort and ventilator synchrony. These potent medications are often administered at high
doses for prolonged periods and are associated with adverse effects such as
bradycardia, hypotension, gut dysmotility, immobility, weakness, and delirium.1-3 Despite protocols and sedation assessment tools that guide
clinicians, patients still experience significant levels of anxiety.4,5
Unrelieved anxiety and fear are not
only unpleasant symptoms that clinicians want to palliate, but increased sympathetic nervous system activity can
cause dyspnea and increased myocardial oxygen demand.6 Sustained anxiety and sympathetic nervous system activation can decrease the ability to
concentrate, rest, or relax.6,7 Mechanically ventilated patients have little control over pharmacological interventions to relieve anxiety; dosing and
frequency of sedative and analgesic medications are controlled by intensive care
unit (ICU) clinicians. Interventions are
For editorial comment see p 2386.

Importance Alternatives to sedative medications, such as music, may alleviate the
anxiety associated with ventilatory support.
Objective To test whether listening to self-initiated patient-directed music (PDM) can
reduce anxiety and sedative exposure during ventilatory support in critically ill patients.
Design, Setting, and Patients Randomized clinical trial that enrolled 373 patients from 12 intensive care units (ICUs) at 5 hospitals in the Minneapolis-St Paul,
Minnesota, area receiving acute mechanical ventilatory support for respiratory failure
between September 2006 and March 2011. Of the patients included in the study, 86%
were white, 52% were female, and the mean (SD) age was 59 (14) years. The patients had a mean (SD) Acute Physiology, Age and Chronic Health Evaluation III score
of 63 (21.6) and a mean (SD) of 5.7 (6.4) study days.
Interventions Self-initiated PDM (n=126) with preferred selections tailored by a
music therapist whenever desired while receiving ventilatory support, self-initiated use
of noise-canceling headphones (NCH; n=122), or usual care (n=125).
Main Outcomes and Measures Daily assessments of anxiety (on 100-mm visual
analog scale) and 2 aggregate measures of sedative exposure (intensity and frequency).
Results Patients in the PDM group listened to music for a mean (SD) of 79.8 (126) (median [range], 12 [0-796]) minutes/day. Patients in the NCH group wore the noise-abating
headphones for a mean (SD) of 34.0 (89.6) (median [range], 0 [0-916]) minutes/day. The
mixed-models analysis showed that at any time point, patients in the PDM group had an
anxiety score that was 19.5 points lower (95% CI, ⫺32.2 to ⫺6.8) than patients in the usual
care group (P=.003). By the fifth study day, anxiety was reduced by 36.5% in PDM patients. The treatment⫻time interaction showed that PDM significantly reduced both measures of sedative exposure. Compared with usual care, the PDM group had reduced sedation
intensity by ⫺0.18 (95% CI, ⫺0.36 to ⫺0.004) points/day (P=.05) and had reduced frequency by ⫺0.21 (95% CI, ⫺0.37 to ⫺0.05) points/day (P=.01). The PDM group had
reduced sedation frequency by ⫺0.18 (95% CI, ⫺0.36 to ⫺0.004) points/day vs the NCH
group (P=.04). By the fifth study day, the PDM patients received 2 fewer sedative doses
(reduction of 38%) and had a reduction of 36% in sedation intensity.
Conclusions and Relevance Among ICU patients receiving acute ventilatory support for respiratory failure, PDM resulted in greater reduction in anxiety compared with
usual care, but not compared with NCH. Concurrently, PDM resulted in greater reduction in sedation frequency compared with usual care or NCH, and greater reduction in sedation intensity compared with usual care, but not compared with NCH.
Trial Registration clinicaltrials.gov Identifier: NCT00440700
JAMA. 2013;309(22):2335-2344
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needed that reduce anxiety, actively involve patients, and minimize the use of
sedative medications.
Nonpharmacological interventions
such as relaxing music are effective in reducing anxiety while reducing medication administration.8,9 Music is a powerful distractor that can alter perceived
levels of anxiety10 by occupying attention channels in the brain with meaningful, auditory stimuli11 rather than
stressful environmental stimuli. Listening to preferred, relaxing music has reduced anxiety in mechanically ventilated patients in limited trials.12-15 It is not
known if music can reduce anxiety
throughout the course of ventilatory support, or reduce exposure to sedative
medications. We evaluated if a patientdirected music (PDM) intervention could
reduce anxiety and sedative exposure in
ICU patients receiving mechanical ventilation.
METHODS
A 3-group, randomized clinical trial design was used. A computer-generated
random numbers list allocated patients to 1 of 3 groups: (1) PDM intervention, (2) active control with noisecanceling headphones (NCH), or (3)
usual care in the ICU. Group assignment was concealed in an opaque envelope. Patients were enrolled from 12
ICUs at 5 hospitals in the Minneapolis-St Paul, Minnesota, area between
September 2006 and March 2011.
Patients were invited to participate
in the study if they were receiving ventilatory support for acute respiratory
failure, were alert, participating in their
daily care routines, appropriately following commands, cognitively intact to
participate in the consent process,
and had adequate or corrected vision
and hearing. Patients were not approached if they were receiving aggressive ventilatory support, requiring vasopressors, unresponsive or delirious,
receiving chronic ventilator support
prior to hospitalization, or had a documented mental incompetence (eg, Alzheimer disease).
The target sample size of 286 was
based on power analysis calculations
2336
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that required 48 hours or longer of protocol data and allowed for 20% attrition. Other parameters were an ␣ level
of .05 and a power level of 80% based
on a repeated-measures analysis of covariance, which provides a good approximation for mixed models. A prior
study16 had a mean (SD) score of 50.5
(29.2) mm on the visual analog scale
for anxiety (VAS-A; scale range: 0-100
mm). A difference of 15.2 mm or greater
would be detected as a statistically significant difference among groups. For
the sedative-exposure aim, previous
data gave a mean (SD) estimate of 6.5
(4.3).17 Using the sample size determined for the VAS-A, any difference of
1.8 or greater in the sedation intensity
would be detected as a statistically significant difference among groups.
Study approval was obtained from
the University of Minnesota’s institutional review board (IRB) and from the
participating hospitals’ IRBs. Given the
patient-directed nature of the protocol, the IRB required patients to provide their own written informed consent. To validate patient understanding
of the study’s risks, benefits, and procedures, the patient had to answer 7 yes
or no questions correctly to the research nurses. If any of the questions
was answered incorrectly, that patient
was not enrolled that day but remained eligible to be reapproached if
mental status improved and inclusion
criteria were still met. Trained research nurses obtained all written consents.
Data were obtained on sex, age, days
mechanically ventilated, and days in the
ICU prior to enrollment, diagnoses,
ventilator settings, and all medications received 24 hours prior to enrollment. Data from each patient’s ICU admission day were abstracted from the
medical record to calculate the Acute
Physiology, Age and Chronic Health
Evaluation III (APACHE III) score,
which was used as a covariate to control for illness severity.
Anxiety was defined as a state marked
by apprehension, agitation, increased
motor activity, arousal, and fearful withdrawal.18 Anxiety was assessed via self-

report at study entry and daily while
ventilated using the 100-mm VAS-A,
which was presented to patients with
a vertical orientation like a thermometer. The bottom of the scale was anchored by the statement “not anxious
at all” and the top was anchored by
“most anxious ever.” Patients indicated their current level of anxiety in
response to “How are you feeling today?” The VAS-A score was the number of millimeters from the bottom edge
of the line anchor to the patient’s mark.
The VAS-A and the Spielberger State
Anxiety Inventory are correlated
(r=0.4916 to r =0.8219), demonstrating
concurrent validity.
Sedative exposure was determined
for all patients who received any of 8
commonly administered sedative and
analgesic medications in the ICU (midazolam, lorazepam, propofol, dexmedetomidine, morphine, fentanyl, hydromorphone, haloperidol) 24 hours
prior to enrollment and each day during the study. Sedative exposure was
operationalized as a daily sedative drug
intensity score and sedative dose frequency.17 The usual practice at the participating ICUs consisted of physicians writing orders for sedation therapy
per their individual preferences with the
nurses managing administration of
these medications within the parameters of the orders. Sedative administration was not directed by a specific
unit protocol or by a study protocol.
The sedative drug intensity score aggregated dose amounts of medications from disparate drug classes by
using a weight-adjusted dose (adjusting for differing patient weights) of each
sedative administered during 4-hour
time blocks during mechanical ventilation. Every drug amount (eg, 2 mg of
lorazepam administered between noon
and 4 PM) was then placed into quartiles created by using all patients’ lorazepam data during the entire time they
received the study protocol; 2 mg of lorazepam might fall into quartile 2. If fentanyl also was given at a dose that fell
into quartile 3 for all fentanyl doses
within the entire sample, then the
noon-4 PM value was 5 (2⫹3). If none
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of the 8 medications was given, the
value was 0. The values were summed
over the six 4-hour blocks to produce
a daily sedative drug intensity score. For
dose frequency, a 24-hour day was divided into six 4-hour time blocks and,
for each of the 8 drugs, the occurrences in which a sedative was administered at least once during that interval were summed. This approach to
sedative exposure accounts for medications administered to patients from
nonequivalent, disparate drug classes.17
The environmental scan form was developed for this study to collect data on
the overall activity level in the patient’s room each shift and on ICU nursing experience. Nurses were invited to
provide any comments about the study
protocol. This paper and pencil form
was adhered to a brightly colored clipboard kept at each participant’s bed side.
A starter set of 6 CDs were reviewed
with the patient by the research nurse
to provide for immediate listening upon
randomization to the PDM group. The
starter set included relaxing music
played on piano, harp, guitar, and Native American flute. The research nurse
oriented the patient to CD player and
headphone operation. A standard CD/
MP3 player with comfortable, noiseabating headphones was kept within
easy reach to allow the patient to selfinitiate music listening.
Within 24 hours of randomization, the
music therapist completed a music preference assessment on each PDM patient
usingatooldesigned to assess music preferences of mechanically ventilated patients with a simple yes or no format.20
Patientswerepromptedverballyandwith
posted signs to use music at least twice
per day when feeling anxious and/or to
provide relaxation, but were encouraged
to self-initiate music listening as frequently as desired. Nursing staff were encouraged to offer music at least twice during their shift, but were reminded by the
research staff that the decision to listen
was determined by the patient. A datalogger system on the headphones captured each PDM session and total daily
music listening time; system details are
described elsewhere.21

Patients randomized to the active
control NCH group were encouraged
to wear headphones whenever they
wanted to block out ICU noise or have
some quiet time. As with the PDM
group, NCH patients self-initiated headphone use. Patients randomized to the
usual care control group received standard ICU care for that respective unit.
Patients had daily assessment visits by
a research nurse who administered the
VAS-A. Patients remained on protocol
up to 30 days as long as they were receiving ventilatory support.
Descriptive statistics and graphing
were performed on all study data to assess the distributions of the variables.
We used bivariate associations to identify covariates to be considered in subsequent analyses. Covariates were not
included to assess their effect per se or
to adjust for imbalance among groups,
but were included if significantly associated with the outcome to subtract the
variability piece they represent and thus
gain efficiency.
Patients with at least 2 days of VAS-A
scores and sedative exposure data were
used in the change over time analyses.
Change over time was assessed as the
slope of the outcome variables determined from one day to the next using
the best fitting line. We used mixedeffects models to analyze anxiety and
sedative exposure (sedation intensity
scores and sedation frequency) because they accommodate measures that
are correlated from one time point to
another and have variances that are not
constant from one time point to another, which would be expected in a
repeated-measures analysis of covariance. This is the recommended modeling for intent-to-treat analyses.22 Using
the data as is within a mixed-model
analysis has a lower type I error and
higher power than any type of imputation method used for missing data,
which would be needed for a repeatedmeasures analysis of covariance. Also,
imputation may result in biased estimates of effects and standard errors. A
series of models were estimated and
compared with the Aikake information criterion and the Bayesian infor-
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mation criterion to determine the best
model of change for the anxiety and
sedative exposure data.
An unconditional means model was
used to assess 2 null hypotheses: no
change across occasions; and no variation among patients. Rejecting these null
hypotheses warrants further analysis. An
unconditional growth model with day
added as a predictor incorporated estimation of change coefficients. Models
with several within-person error covariance structures that were compatible
with the correlation pattern between
anxiety measures and sedative exposure measures at different time points
were explored. The best fit was the autoregressive plus random-effects covariance structure that assumes correlations decrease as the lag time increases
and that covariance also comes from
measures within subject. An unconditional growth model with a quadratic
term was also explored to assess if there
were nonlinear changes in sedative exposure measures over time.
A conditional growth model introduced the effect of the intervention and
included any covariates found to be associated with the outcome. These were
included in the analysis to eliminate the
variability attached to them and improve the precision of the ␤ estimates.
Post hoc multiple comparisons were
completed within the mixed modeling controlling the overall ␣ level at .05.
We used SPSS version 17 (SPSS Inc) and
SAS version 9.2 (SAS Institute Inc) statistical software. Final parameter estimates were considered significant at a
P value of .05 or less with a 2-sided ␣.
RESULTS
TABLE 1 summarizes the characteristics of the patients. The mean age was
59 years with a wide range of APACHE
III scores. The primary indication for
mechanical ventilation was respiratory failure or distress. Only median
ICU days prior to enrollment were significantly different at study entry; NCH
patients were in the ICU 1 to 2 days longer prior to enrollment than PDM or
usual care patients. Patients remained
on protocol for a mean (SD) of 5.7 (6.4)
JAMA, June 12, 2013—Vol 309, No. 22 2337
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days (median, 3.2 [range 1-30] days).
FIGURE 1 details patient flow through
the study.
The PDM patients listened to music
for a mean (SD) of 79.8 (126) minutes/
day (median, 12 [range, 0-796] minutes/day). The NCH patients wore the
noise-abating units for a mean (SD) of

34.0 (89.6) minutes/day (median, 0
[range, 0-916] minutes/day). There was
no linear relationship between device
use time and anxiety for either the PDM
group (r = 0.07; P = .14) or the NCH
group (r=⫺0.06; P=.23). More PDM
patients were extubated at the end of
the study (Table 1).

Table 1. Demographic and Clinical Characteristics of Patients (N = 373)
Patient-Directed
Music
(n = 126)
Age, mean (SD), y
Female sex, No. (%)
APACHE III score, mean (SD)
Length of ICU stay prior to study entry, median
(range), d
Ventilator use, median (range), d
Prior to study entry
Prior to study entry ⫹ study days
Enrolled per protocol, median (range), d
VAS-A score at study entry, mean (SD), mm
Sedation 24 h prior to enrollment, median (range)
Intensity score
Frequency
Extubated at end of study, No. (%)
Alive at end of study, No. (%)
Primary ICU admission diagnosis category, No. (%)
Pulmonary
Cardiac
Medical
Surgical
Sepsis or infection

Noise-Canceling
Usual
Headphones
Care
P
(n = 122)
(n = 125) Value

60.4 (15.4)

59.4 (14.3)

68 (54)

56 (46)

57.8 (13.5) .37

63.1 (18.7)

62.2 (22.3)

65.6 (23.5) .43

6 (0-40)

8 (1-85)

7 (0-33) .02

69 (55)

4.5 (0-35)

6.0 (1-79)

6.0 (0-38) .11

7.5 (1-53)

7.3 (1-47)

7.7 (1-46) .74

3.0 (1-27)

3.6 (1-30)

3.8 (1-30) .66

51.9 (32.4)

49.0 (30.1)

52.3 (29.7) .66

4.0 (0-12)

3.5 (0-10)

4.0 (0-12) .07

7.0 (0-18)

6.0 (0-19)

6.0 (0-14) .14

89 (71)

67 (55)

83 (66)

.02

115 (91)

111 (91)

109 (87)

.65

77 (61)

70 (57)

71 (57)

14 (11)
0

9 (7)

9 (7)

3 (2)

3 (2)

10 (8)

7 (6)

6 (5)

Gastrointestinal

6 (5)

8 (7)

7 (6)

Neurological or neuromuscular

2 (2)

6 (5)

7 (6)

Oncology

4 (3)

3 (2)

4 (3)

Shock or hypotension

3 (2)

2 (2)

5 (4)

Trauma

3 (2)

4 (3)

2 (2)

Surgical

2 (2)

3 (2)

0

Vascular

2 (2)

0

2 (2)

Other or missing

3 (2)

7 (6)

9 (7)

Indication for mechanical ventilation, No. (%)
Respiratory failure

63 (50)

63 (52)

61 (49)

32 (25)

27 (22)

36 (29)

Pneumonia

7 (6)

5 (4)

7 (6)

Respiratory arrest

3 (2)

4 (3)

4 (3)

Airway protection

2 (1)

5 (4)

4 (3)

Surgery or postoperative

2 (1)

3 (2)

4 (3)

COPD

7 (6)

4 (3)

0

Hypoxia

2 (1)

3 (2)

2 (2)

ARDS

1 (1)

1 (1)

0

Tachypnea

1 (1)

0

1 (1)

Cardiac arrest

4 (3)

2 (2)

5 (4)

Pulmonary edema

1 (1)

0

0

Asthma

0

0

1 (1)

Other or missing

1 (1)

5 (4)

0

Respiratory distress

.28

Abbreviations: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III; ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; VAS-A, visual analog scale for anxiety.

2338

JAMA, June 12, 2013—Vol 309, No. 22

Downloaded From: on 02/19/2018

The analysis is from the 241 patients with 2 or more anxiety assessments in order to model change. Not
all patients were able to provide anxiety assessments each day due to fatigue, medical condition, state of sedation, inability or refusal to complete
assessments, or were off the unit
(Figure 1). Unadjusted mean VAS-A
score was not significantly different
among groups at study entry (Table 1).
We did not observe a nonlinear pattern or any obvious inflection point in
the individual patterns of change; therefore, change was modeled as linear.
Both the unconditional means model
and the unconditional growth model indicated significant unexplained variance that warranted further modeling.
Covariates of interest in the model were
scores on the APACHE III and VAS-A
at enrollment and sedative exposure.
Two final models were produced
using either sedation frequency or sedation intensity (TABLE 2). After the adjustment due to APACHE III and sedation frequency and intensity, the
adjusted baseline VAS-A score was different among study groups, and the interaction of baseline with treatment
group was significant. Pairwise comparisons indicated that PDM patients
had a significantly lower VAS-A score
at study entry than usual care patients, regardless of whether sedation
intensity or frequency was used. Sedation intensity (␤=0.75 [95% CI, 0.01
to 1.50]; P = .05) was associated with
higher VAS-A scores. After adjusting for
these covariates, the final models
showed that the main effect of PDM was
to lower VAS-A scores consistently by
more than 19 mm during the study period compared with usual care (sedation intensity: ␤=⫺19.3 [95% CI, ⫺32
to ⫺6.6]; and sedation frequency:
␤ = ⫺19.5 [95% CI, ⫺32.2 to ⫺6.8];
P=.003 for both) (FIGURE 2).
The analysis is from the 266 patients who were on protocol for 48
hours or longer. A linear pattern of
change was supported by graphs of sedation intensity and frequency over
time. Sedation frequency and intensity were not significantly different

©2013 American Medical Association. All rights reserved.
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among groups 24 hours prior to study
entry (Table 1).
Covariates associated with sedation
intensity and sedation frequency were
age, sex, and APACHE III scores. Age
was significant in both models; the
higher the age, the lower the sedation
intensity or sedation frequency. In the
models, there was a significant interaction between the PDM group and
time, which showed a decrease in sedation intensity and sedation frequency over time (per day) for the PDM
group only (Table 2). In post hoc pairwise comparisons, the PDM group had
a greater decrease in the change over
time of the sedation intensity score
compared with the usual care group
(␤=⫺0.18 [95% CI, ⫺0.36 to ⫺0.004];

P = .05). Using the sedation frequency
measure, the PDM group had a greater
decrease in the change over time compared with the usual care group
(␤ =⫺0.21 [95% CI, ⫺0.37 to ⫺0.05];
P=.01) and the NCH group (␤=⫺0.18
[95% CI, ⫺0.36 to ⫺0.004]; P = .04)
(FIGURE 3 and FIGURE 4).
For an average patient on the fifth
study day (the average time patients
were enrolled), a usual care patient received 5 doses of any 1 of the 8 studydefined sedative medications. An
equivalent PDM patient received just 3
doses on the fifth day, a relative reduction of 38%. By the end of the fifth day,
an average usual care patient had a sedation intensity score of 4.4. An equivalent PDM patient had a sedation inten-

sity score of 2.8, a relative reduction of
36%. By the end of the fifth day, an average usual care patient had an anxiety score of 52. An equivalent PDM patient had an anxiety score of 33, which
is an absolute difference of 19 on a 100point scale and a relative reduction of
36.5% (TABLE 3).
Nurses caring for patients had a median of 5.9 years (range, 0.25-44 years)
of ICU experience. When asked to appraise the shift activity in the patient’s
room, 21% of the nurses said quiet, 49%
said it was at a usual pace, 24% said it
was busy, 6% said it was very busy to
hectic. Comments included the nurses’
efforts offering PDM or headphones to
patients and their observations of the
protocol (BOX).

Figure 1. Flow Diagram of Study
7074 Patients assessed for eligibility a

6701 Excluded
5627 Did not meet inclusion criteria
748 Refused to participate
326 Unable to complete consent process
107 Sedation
83 Confusion
74 Fatigue
54 Unspecified
8 Family request

373 Randomized

126 Randomized to receive patientdirected music
122 Received patient-directed
music as randomized
4 Did not receive patient-directed
music as randomized
3 Ineligible on chart review
1 Unable to wear equipment

122 Randomized to receive noise-canceling
headphones only
118 Received noise-canceling
headphones only as randomized
4 Did not receive noise-canceling
headphones only as randomized
2 Ineligible on chart review
2 Withdrew due to group assignment

125 Randomized to receive usual care
124 Received usual care as randomized
1 Did not receive usual care as
randomized (ineligible on chart review)

0 Lost to follow-up
8 Discontinued intervention
2 Disliked equipment
2 No reason given
1 Family request
1 Too tired
2 Removed after protocol initiation
1 Worsening physiological status
1 Protocol deviation

0 Lost to follow-up
8 Discontinued intervention
1 Disliked equipment
3 No reason given
1 Family request
3 Removed after protocol initiation
1 Worsening physiological status
2 Unable to complete assessments

0 Lost to follow-up
4 Discontinued intervention
1 No reason given
3 Removed after protocol initiation
2 Worsening physiological status
1 Protocol deviation

82 Included in anxiety analysis b
44 Excluded from anxiety analysis
(<2 anxiety measurements c)

76 Included in anxiety analysis b
46 Excluded from anxiety analysis
(<2 anxiety measurements c)

83 Included in anxiety analysis b
42 Excluded from anxiety analysis
(<2 anxiety measurements c)

87 Included in sedation analysis b
35 Excluded from sedation analysis
(<48 h in study)

90 Included in sedation analysis b
28 Excluded from sedation analysis
(<48 h in study)

89 Included in sedation analysis b
35 Excluded from sedation analysis
(<48 h in study)

a This number is an estimate based on the number of days patients were mechanically ventilated, screened, and had confirmed pulmonary diagnosis.
b Those who withdrew or were removed after completing at least 48 hours in the study were included in the analysis.
c The reasons why anxiety assessment was not completed included sedated, sleeping, off unit, too tired, and unable to respond to questions.
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DISCUSSION
The 2 primary study aims were to determine if PDM reduced anxiety and
sedative exposure in a sample of patients receiving mechanical ventilatory support. The PDM intervention decreased anxiety and sedative exposure
over time more effectively than usual
care or NCH. To our knowledge, these
findings are from the first randomized
clinical trial to test an integrative

therapy for self-management of anxiety in ventilated ICU patients that does
not rely solely on medications. The
unique approach involving patients
themselves in self-management of anxiety launches a novel area of ICU clinical research.
The PDM protocol was modeled after the patient-controlled analgesia intervention whereby patients report better pain control and are more satisfied

when they self-administer analgesic
therapy.8,23,24 Music provides patients
with a comforting and familiar stimulus and the PDM intervention empowers patients in their own anxiety management; it is an inexpensive, easily
implemented nonpharmacological intervention that can reduce anxiety, reduce sedative medication exposure, and
potentially associated adverse effects.25-29 The PDM patients received less

Table 2. Final Models for Anxiety and Sedative Exposure Based on 2 or More Days of Data a
Model Results for VAS-A (n = 241)
Sedation Frequency
␤ (95% CI) b
Intercept e

P
Value

Model Results for Sedation (n = 266)

Sedation Intensity
P
Value

␤ (95% CI) b

Intensity
␤ (95% CI) c

Frequency
P
Value

␤ (95% CI) d

P
Value

35.6
(23.3 to 48.0)

⬍.001

34.9
(22.6 to 47.2)

⬍.001

5.3
(3.5 to 7.1)

⬍.001

Day

⫺0.50
(⫺1.10 to 0.05)

.08

⫺0.51
(⫺1.10 to 0.04)

.07

⫺0.03
(⫺0.15 to 0.09)

.65

VAS-A score at day 0

0.11
(⫺0.05 to 0.27)

.18

0.11
(⫺0.05 to 0.27)

.18

Patient-directed music

⫺19.5
(⫺32.2 to ⫺6.8)

.003

⫺19.3
(⫺32.0 to ⫺6.6)

.003

0.14
(⫺0.92 to 1.20)

.79

0.69
(⫺0.68 to 2.10)

.33

Noise-canceling headphones

⫺8.3
(⫺21.4 to 4.8)

.22

⫺8.3
(⫺8.7 to ⫺7.9)

.21

0.18
(⫺0.86 to 1.20)

.73

⫺0.01
(⫺1.30 to 1.30)

.99

APACHE III score

0.16
(0.02 to 0.30)

.02

0.16
(0.02 to 0.30)

.02

0.003
(⫺0.01 to 0.02)

.79

0.005
(⫺0.01 to 0.02)

.65

Age

⫺0.03
(⫺0.05 to ⫺0.01)

.03

⫺0.04
(⫺0.08 to ⫺0.008)

.03

Sex

0.88
(0.15 to 1.60)

.02

0.94
(0.02 to 1.90)

.047

⫺0.18
(⫺0.36 to ⫺0.004)

.05

⫺0.21
(⫺0.37 to ⫺0.05)

.01

⫺0.08
(⫺0.24 to 0.08)

.32

⫺0.03
(⫺0.17 to 0.11)

.72

Patient-directed music ⫻ day
Noise-canceling headphones ⫻ day
Adjusted sedation
Intensity
Frequency
VAS-A score at day 0 ⫻
Patient-directed music
Noise-canceling headphones
Pairwise comparisons f
Patient-directed music vs noise-canceling
headphones
Patient-directed music vs usual care
Noise-canceling headphones vs usual care

0.75
(0.01 to 1.50)

.05

7.3
(5.1 to 9.5)

⬍.001

⫺0.17
⬍.001
(⫺0.27 to ⫺0.07)

0.42
(⫺0.15 to 0.99)

.14

0.25
(0.03 to 0.47)

.02

0.25
(0.03 to 0.47)

.02

0.11
(⫺0.13 to 0.35)

.33

0.12
(⫺0.12 to 0.36)

.32

0.14
(⫺0.08 to 0.36)

.24

0.13
(⫺0.09 to 0.35)

.24

⫺0.09
(⫺0.27 to 0.09)

.32

⫺0.18
(⫺0.36 to ⫺0.004)

.04

0.25
(0.03 to 0.47)

.02

0.25
(0.03 to 0.47)

.02

⫺0.18
(⫺0.36 to ⫺0.004)

.05

⫺0.21
(⫺0.37 to ⫺0.05)

.01

0.11
(⫺0.13 to 0.35)

.33

0.12
(⫺0.12 to 0.36)

.32

⫺0.08
(⫺0.24 to 0.08)

.32

⫺0.03
(⫺0.17 to 0.11)

.72

Abbreviations: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III; VAS-A, visual analog scale for anxiety.
a The following sentence is an example of how to interpret this table. The formula to predict sedation frequency for the patient-directed music group at any time point: sedation
frequency=7.3 minus 0.17 (day in study) minus 0.21 (day if in the patient-directed music group) plus 0.69 (if in the patient-directed music group) plus 0.005 (APACHE III score)
minus 0.04 (age) plus 0.94 (if female).
b Indicates change in millimeters for VAS-A for 1 unit change in predictor.
c Indicates change in sedation intensity for 1 unit change in predictor.
d Indicates change in sedation frequency for 1 unit change in predictor.
e Represents the overall average of frequency sedation at baseline (7.3 doses). Each patient’s dose decreased by an average of 0.17 doses per day. If the patient was in the
patient-directed music group, for each day, the dose frequency decreases by another 0.21 points per day (0.17⫹0.21=0.38). If the patient was in the patient-directed music
group, the baseline average was 0.69 higher (7.30⫹0.69=7.99), every increase of 1 point in the APACHE III score raises the total daily dose frequency by another 0.005. For
every 1 year older a patient was, his/her sedation frequency decreased by 0.04 points. If the patient was female, the dose frequency increased by 0.94.
f The data in columns 2 through 5 are for VAS-A scores at day 0.
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Figure 2. Visual Analog Scale for Anxiety Scatterplots by Group
Noise-canceling headphones
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The diagonal and horizontal lines are the best fitted lines to demonstrate change over the study period.

Figure 3. Sedation Intensity Scatterplots by Group
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frequent and less intense sedative regimens while reporting decreased anxiety levels.
We report a reduction in sedative exposure with PDM using a method to aggregate medications from disparate drug

classes. This is a significant finding in that
strategies are needed to reduce the
amount and frequency sedative medications are administered to mechanically
ventilated ICU patients. An appropriately
tailored music intervention holds great

promise for use in clinical practice as a
method to potentially avoid or reduce the
cumulative adverse effects of these potent
medications, but requires further study.
As more clinicians are advocating to
minimize sedative administration,30,31

Figure 4. Sedation Frequency Scatterplots by Group
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Table 3. Visual Analog Scale for Anxiety (VAS-A) and Sedative Exposure Using Mixed-Effects Models a
Estimated VAS-A Score, mm
Using Sedation Intensity b

Median score

APACHE
III Score
64

Sedation Score
Intensity
4

Frequency
7

Baseline
VAS-A
Score,
mm
52

PatientDirected
Music
33

Using Sedation Frequency c

NoisePatientNoiseCanceling
Usual
Directed
Canceling
Headphones
Care
Music
Headphones
44
52
32
43
Estimated Sedation Measures
Intensity d

Median score

64

4

7

Female
sex

2.8

4.2

Usual
Care
51

Frequency e
4.4

3.3

5.2

5.3

Abbreviation: APACHE III, Acute Physiology, Age and Chronic Health Evaluation III.
a Sedative exposure defined as the dose frequency and the sedation intensity. Patient age of 60 years, APACHE III scores, and study day 5 kept constant throughout model.
b It would be estimated that the usual care group would have an anxiety rating of 52 mm at 5 days into the study. For the noise-canceling headphones group, they would have an
anxiety rating of 44 mm, a decrease of 8 points (in millimeters). For the patient-directed music group, they would have an anxiety rating of 33 mm, a decrease of 19 mm from usual
care at 5 days into the study. By day 5, patient-directed music reduces VAS-A score by 37% compared with usual care.
c The usual care group would have an anxiety rating of 51 mm at 5 days into the study. The noise-canceling headphones group would have an anxiety rating of 43 mm, a decrease
of 8 points (in millimeters). The patient-directed music group would have an anxiety rating of 32 mm, a decrease of 19 mm from usual care. By day 5, patient-directed music
reduces VAS-A score by 37% compared with usual care.
d Indicates the sum of the dose quartiles over 8 medications. For an average patient with usual care, his/her sedation intensity score would be 4.4 at 5 days into the study. The
noise-canceling headphones group would be 4.2, a decrease of 0.2. The patient-directed music group would be 2.8, a decrease of 1.6 from usual care. By day 5, patientdirected music reduces sedation intensity by 36% compared with usual care.
e For an average patient in usual care, his/her sedation frequency score would be 5.3 at 5 days into the study. The noise-canceling headphones group would be 5.2, a decrease of
0.1. The patient-directed music group would be 3.3, a decrease of 2.0 from usual care at 5 days. By day 5, patient-directed music reduces sedation frequency by 38% compared
with usual care.
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our data suggest that patients still experience moderate levels of anxiety. Patients in this study with higher sedation intensity scores had higher VAS-A
scores. This finding is consistent with
previous investigations that demonstrate ICU patients report moderate
anxiety levels throughout the course of
ventilatory support, despite receiving
sedative medications.7 Given the detrimental physiological and psychological effects of sustained anxiety, it is important that this symptom be effectively
managed. As clinicians seek lighter
sedative regimens in the ICU, PDM may
be an appropriate adjunctive intervention by which patients can selfmanage anxiety. There were no comments from nurses that would suggest
the study protocol was burdensome to
their patient care practices.
Because patients were enrolled
when they were not receiving high
levels of sedative medications (otherwise they would have been too
sedated to provide consent at enrollment), it is difficult to interpret the
pharmacological or cost significance
of a reduction in sedative exposure in
the days after enrollment compared
with the higher doses patients likely
received earlier in their episode of
respiratory failure. However, even
with a modest reduction in sedative
exposure, patients assigned to PDM
also experienced less anxiety compared with usual care.
There are a number of limitations to
this study. Because research nurses
completed the anxiety assessments (to
ensure consistent administration and
minimize influence on the bedside
nurse’s practice), only 1 anxiety assessment was performed daily. For some patients, the assessment was not performed in relation to use of the PDM
intervention, and if the patient was not
available or the patient deferred due to
fatigue, medical condition, or was sedated, the assessment was not completed (Figure 1).
Because the intervention was initiated by the patient, not all those randomized to PDM actually used music
twice daily. Some patients may have re-

Box. Summary of Intensive Care Unit Nurse Written Comments
and Observations
Patient-directed music group
Patient’s wife says he listens to the music all of the time and it has been working
well. Patient was sleeping with headphones on with his wife sleeping next to
him in a chair.
Patient looks very peaceful and states she likes the music.
Patient was tapping fingers to some of the music provided to him by the music
therapist.
Patient listened to music most of yesterday (about 10 h). Tends to be anxious
and her blood pressure is lower when she is listening to music.
Patient likes music and always nods head “yes” to have headphones in place
when asked.
After putting headphones on, patient appears less anxious.
Patient wears headphones very often and rests well with them in place. Always
nods “yes” to wearing headphones.
Patient has been tapping feet to the music and listens for a couple of hours each
night; seems happy with it!
After putting headphones on, patient appears less anxious.
Able to decrease propofol slightly.
Evening was quieter. Patient put headset on which seemed to help a lot.
Family visited for 1 h. Patient had difficulty sleeping; tried reading and quiet
time before using headphones.
Patient calm and resting with headphones on.
Patient was relaxing with music on for 3 h.
Patient slept well, headphones for 3 h.
Music was on entire night (8-h shift).
Noise-canceling headphones group
Patient really benefited from headphones!
Patient relaxed with headphones.
I’m glad he’s participating. I think the headphones will help him rest.
The headphones would help her get more rest (due to the commotion on the
other side of the curtain with roommate).
The patient wanted to wear the headphones most of the day yesterday and communicated that they helped her rest.
Patient put headphones on without prompting.
Headphones helped patient sleep during dialysis.
Patient wanted to wear headphones all night.
Patient had earphones on about 1 h early in the night, then declined to use them
the rest of night.
Headphones decrease nerves (per patient and patient’s wife).
Patient appeared calmer with headphones on.

lied on the bedside nurse to assist with
the equipment. This may have affected the length or frequency of music listening by patients or the nonsignificant relationship between music
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listening time and anxiety. However,
simply having the option and availability of PDM may provide patients a sense
of control over one aspect of their
ICU care. Given that anxiety is an
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individually perceived symptom, selfinitiation of treatment with music
whenever desired and for as long as desired is the preferred method of music
listening much in the same manner
as patient-controlled analgesia for pain
relief.
Only a small number of nurses provided written comments about the protocol. While positive, it is unknown if
the ICU nurses were reluctant to record negative comments, despite the
comments being anonymous. We did
not query nurses for the reasons why
they administered sedative medications to study patients. The ICU nurses
were not blinded to assignment group,
which may have introduced bias into
the study. Furthermore, we did not collect data from patients after they were
extubated or transferred from the ICU.
CONCLUSIONS
Among ICU patients receiving acute
ventilatory support for respiratory failure, PDM resulted in greater reduc-
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